Medicina generale

European Medicines Agency recommends suspension of marketing authorisations for meprobamate-containing medicines in the European Union

The European Medicines Agency has recommended the suspension of all marketing authorisations for meprobamate-containing medicines for oral use in the European Union, because their risks, particularly the risk of serious side effects affecting the nervous system, are greater than their benefits.
Approfondisci

 http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_e...

EMA - European Medicines Agency